A Subset of FOXO1‐Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and “Burkitt‐Like” Morphology Is Associated With High Amplification of MYCL : A Report From the Children's Oncology Group
Genes, Chromosomes and Cancer · 2026-10 · 65 (10)
DOI: 10.1002/gcc.70181 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 23.10.2026. Verfasst von Sonja Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Forkhead Box Protein O1, Rhabdomyosarcoma, Alveolar, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors. Die Arbeit nennt 25 Literaturangaben. Gefördert von: NCTN Statistics & Data Center, Pfizer, Human Specimen Banking in NCI-Sponsored Clinical Trials.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
Alveolar rhabdomyosarcoma (ARMS) is a distinct histologic subtype of rhabdomyosarcoma, associated with the presence of a PAX3 or PAX7::FOXO1 gene fusion in approximately 80% of cases. Adverse outcomes for patients with ARMS are associated with the presence of a FOXO1 gene fusion; however, additional genetic markers are necessary to better characterize FOXO1 ‐fusion negative ARMS.
Methods
We reviewed the histology of 306 diagnostic biopsies from participants enrolled in the recent Children's Oncology Group (COG) trial ARST1431. Ultra‐low pass whole genome sequencing and custom panel sequencing were performed on all diagnostic biopsies with available material.
Results
Histologic review of diagnostic specimens from ARST1431 identified two cases with predominantly ARMS histology (small round cells with uniform, round nuclei) that were distinctive compared to other cases with ARMS histology due to the presence of: (a) distinctive large nucleoli with coarse chromatin, (b) amphophilic cytoplasm, (c) abundant karyorrhexis, and (d) admixed tingible body macrophages—all strongly resembling the histologic features of Burkitt lymphoma. Each case showed diffuse myogenin reactivity and lacked evidence of a FOXO1 gene rearrangement by FISH and expanded molecular testing. Tumor sites included the perianal region (2‐year‐old male) and upper extremity (1‐year‐old female). Sequencing studies identified high amplification (> 50 copies) of the MYCL proto‐oncogene in both cases. Retrospective analysis of the amplification data available for ARST1431 identified one additional case in a 15‐year‐old male with high amplification of MYCL and similar histologic features that were more difficult to identify in a limited biopsy sample. The two former patients experienced recurrence and died of disease, while the third patient was alive without recurrence.
Conclusions
We hypothesize that the distinctive histologic phenotype of these three cases is driven by high‐level MYCL amplification (> 50 copies). With an incidence of 1.6% in this series, these unique histologic features may be useful to further identify and characterize FOXO1 ‐fusion negative ARMS. Review of additional cases will be required to determine the clinical significance of this unique histologic pattern with MYCL amplification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Pathology and Laboratory Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Department of Biostatistics, University of Florida, Gainesville, Florida, USA.
- Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
ORCID-Profile: Sonja Chen, Julia Schiantarelli, Natalie B Collins, Erin R Rudzinski, Archana Shenoy, Abha Gupta, Suzanne Wolden, Roshni Dasgupta, Rajkumar Venkatramani, Kelly Klega, Brian D Crompton
Förderung
- NCTN Statistics & Data Center
- Pfizer
- Human Specimen Banking in NCI-Sponsored Clinical Trials
- NCI NIH HHS
- NCTN Network Group Operations Center Grant
Zitieren
APA
Chen, S., Xue, W., Ricker, C. A., Schiantarelli, J., Collins, N. B., Rudzinski, E. R., Shenoy, A., Teot, L. A., Gupta, A., Wolden, S., Dasgupta, R., Venkatramani, R., Klega, K., Arnold, M. A., & Crompton, B. D. (2026). A Subset of FOXO1‐Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and “Burkitt‐Like” Morphology Is Associated With High Amplification of MYCL : A Report From the Children's Oncology Group. Genes, Chromosomes and Cancer, 65(10). https://doi.org/10.1002/gcc.70181
Vancouver
Chen S, Xue W, Ricker CA, Schiantarelli J, Collins NB, Rudzinski ER, et al. A Subset of FOXO1‐Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and “Burkitt‐Like” Morphology Is Associated With High Amplification of MYCL : A Report From the Children's Oncology Group. Genes, Chromosomes and Cancer. 2026;65(10). doi:10.1002/gcc.70181
BibTeX
@article{Chen2026,
author = {Chen, Sonja and Xue, Wei and Ricker, Cora A and Schiantarelli, Julia and Collins, Natalie B and Rudzinski, Erin R and Shenoy, Archana and Teot, Lisa A and Gupta, Abha and Wolden, Suzanne and Dasgupta, Roshni and Venkatramani, Rajkumar and Klega, Kelly and Arnold, Michael A and Crompton, Brian D},
title = {A Subset of FOXO1‐Fusion Negative Rhabdomyosarcoma With Round Cell (Alveolar) and “Burkitt‐Like” Morphology Is Associated With High Amplification of MYCL : A Report From the Children's Oncology Group},
journal = {Genes, Chromosomes and Cancer},
year = {2026},
volume = {65},
number = {10},
doi = {10.1002/gcc.70181}
}
EUVIMED